Virulence properties of Pseudomonas aeruginosa lacking the extreme- stress sigma factor AlgU (σ(E))

Infection and Immunity

Volumn 64, Issue 7, 1996, Pages 2774-2781

  Yu, H ^a   Boucher, J C ^a   Hibler, N S ^a   Deretic, V ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIGMA FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE; STRESS;

EID: 0029883416     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.7.2774-2781.1996     Document Type: Article

References (56)

1. Baltimore, R. S., C. D. C. Christie, and G. J. Walker-Smith. 1989. Immunohistopathological localization of Pseudomonas aeruginosa mucoid exopolysaccharjde. Infect. Immun. 49:281-285.
2. Barton, A. D., K. Ryder, R. V. Lourenco, W. Dralle, and S. G. Weiss. 1976. Inflammatory reaction and airway damage in cystic fibrosis. J. Lab. Clin. Med. 88:423-426.
3. Bodey, G. P., R. Bolivar, V. Fainstein, and L. Jadeja. 1983. Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis. 5:279-313.
4. Boucher, J. C., J. Martinez-Salazar, M. J. Schurr, M. Mudd, H. Vu, and V. Deretic. 1996. Two distinct loci affecting conversion to mucoidy in cystic fibrosjs encode homologs of the serine protease HtrA. J. Bacteriol. 178:511-523.
5. Cryz, S. J., Jr., E. Furer, and R. Germanier. 1983. Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect. Immun. 39:1067-1071.
6. Deretic, V.1996. Molecular biology of mucoidy in Pseudomonas aeruginosa. Cyst. Fibros. Curr. Top. 3:223-244.
7. Deretic, V, M. J. Schurr, J. C. Boucher, and D. W. Martin. 1994. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J. Bacteriol. 176:2773-2780.
8. Deretic, V., M. J. Schurr, and H. Yu. 1995. Pseudomonas aeruginosa, mucoidy and chronic infection phenotype in cystic fibrosis. Trends Microbiol. 3:351-356.
9. DeVries, C. A., and D. E. Ohman. 1994. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J. Bacteriol. 176:6677-6687.
10. Doggett, R G., G. M. Harrison, R. N. Stillwell, and E. S. Wallis. 1966. An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas. J. Pediatr. 68:215-221.
11. Ericksop, J. W., and C. A. Gross. 1989. Identification of the subunit of Escherichia coli RNA polymerase: a second alternate σ factor involved in high-temperature gene expression. Genes Dev. 3:1462-1471.
12. Fleishmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Klrkness, A. R. Kerlavage, C. J. Bull, J.-F. Tomb, B. A. Doughetry, J. M. Merrick, K. McKeenney, G. Sulton, W. FjtzHugh, C. Fields, J. D. Gocayne, J. Scott, R. Shirley, L.-l. Lieu, A. Glodek, J. M. Kelley, J. F. Weidman, C. A. Phillips, T. Spriggs, E. Hedblom, M. D. Cotton, T. R. Utterback, M. C. Hanna, D. T. Nguyen, D. M. Saudek, R. C. Brandon, L. D. Fine, J. L. Fritchman, J. L. Fuhrmann, N. S. M. Georghagen, C. L. Gnehm, L. A. McDonald, K. V. Small, C. M. Fraser, H. O. Smith, and J. C. Venter. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:4,96-512.
13. Fyfe, J. A. M., and J. R. W. Govan. 1980. Alginate synthesis in mucoid Pseudomonas aeruginosa: a chromosomal locus involved in control. J. Gen. Microbiol. 119:443-450.
14. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosjs. Clin. Microbiol. Rev. 4:35-51.
15. Goldberg, J. B., M. J. Coyne, A. N. Neely, and I. A. Holder. 1995. Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect. Immun. 63:4166-4169.
16. Goldberg, J. B., W. L. Gorman, J. L. Flynn, and D. E. Ohman. 1993. A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J. Bacteriol. 175:1303-1308.
17. Govan, J. R. W., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Brit. Med. Bull. 48:912-930.
18. Hancock, R. E. W., L. M. Mutharia, L. Chan, R. P. Darreau, D. P. Speert, and G. B. Pier. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42:170-177.
19. Hassett, D. J., H. P. Schweizer, and D. E. Ohman. 1995. Pseudomonas aeruginosa sodA and sodB mutants defective in manganese- and iron-cofactored Superoxide dismutase activity demonstrate the importance of the ironcofactored form in aerobic metabolism. J. Bacteriol. 177:6330-6337.
20. Hatano, K., J. B. Goldberg, and G. B. Pier. 1995. Biologic activities of antibodies to the neutral-polysaccharide component of the Paeudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Infect. Immun. 63:21-26.
21. Johansen, H. K., and N. Hoiby. 1992. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47:109-111.
22. Johnson, K., I. Charles, G. Dougan, D. Pickard, P. O'Gaora. G. Costa, T. Ali, I. Miller, and C. Hormaeche. 1991. The role of stress-response protein in Salmonella typhimurium virulence. Mol. Microbiol. 5:401-107.
23. Klebanoff, S. J., and R. A. Clark. 1978. The neutrophil: function and clinical disorders. North-Holland Publishing Co., Amsterdam.
24. Koch, C., and N. Hoiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341:1065-1069.
25. Learn, D. B., E. P. Brestel, and S. Seetharama. 1987. Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect. Immun. 55:1813-1818.
26. Leffel, M. S., and J. K. Spitznagel. 1974. Intracellular and extracellular degradation of human polymorphonuclear azurophil and specific granules induced by immune complexes. Infect. Immun. 10:1241-1249.
27. Lipinska, B., O. Fayel, L. Baird, and C. Georgopoulos. 1989. Identification, characterization, and mapping of the Escherichia coli htrA gene, whose product is essential for bacterial growth only at elevated temperatures. J. Bacteriol. 171:1574-1584.
28. Lonelto, M. A., K. L. Brown, K. E. Rudd, and M. J. Buttner. 1994. Analysis of the Streplomyces coelicolor sigE gene reveals the existence of a subfamily of eubacterial RNA polymerase a factors involved in the regulation of extracytoplasmic functions. Proc. Natl. Acad. Sci. USA 86:7573-7577.
29. Luzar, M. A., and T. C. Montie. 1985. Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa. Infect. Immun. 50:572-576.
30. Luzar, M. A., M. J. Thomassen, and T. C. Montie. 1985. Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect. Immun. 50:577-582.
31. Mandell, G. L. 1974. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect. Immun. 9:337-341.
32. Martin, D. W., B. W. Holloway, and V. Deretic. 1993. Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor. J. Bacteriol. 175:1153-1164.
33. Martin, D. W., M. J. Schurr, M. H. Mudd, and V. Dcrelic. 1993. Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy. Mol. Microbiol. 9:495-506.
34. Martin, D. W., M. J. Schurr, M. H. Mudd, J. R. W. Govan, B. W. Holloway, and V. Deretic. 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 90:8377-8381.
35. Martin, D. W., M. J. Schurr, H. Yu, and V. Deretic. 1994. Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to stress response. J. Bacteriol. 176:6688-6696.
36. Metcalf, J. A., J. I. Gallin, W. M. Nauseef, and R. Root. 1986. Laboratory manual of neutrophil function. Raven Press, New York.
37. Mizgerd, J. P., and J. D. Brain. 1995. Reactive oxygen species in the killing of Pseudomonas aeruginosa by human leukocytes. Curr. Microbiol. 31:124-128.
38. Pedersen, S. S. 1992. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS 100(Suppl. 28): 1-79.
39. Phair, J. P., H. P. Bassaris, J. E. Williams, and E. Metzger. 1983. Bacteremic pneumonia due to gram-negative bacilli. Arch. Intern. Med. 143:2147-2149.
40. 24) heat shock sigma factor of Escherichia coli. EMBO J. 14:1043-1055.
41. Rakita, R. M., B. R. Michel, and H. Rosen. 1990. Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. Biochemistry 29:1075-1080.
42. Ramakrishman, L., and S. Falkow. 1994. Mycobaclerium marinum persists in cultured mammalian cells in a temperature-restricted fashion. Infect. Immun. 62:3222-3229.
43. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. J. Amer. Hyg. 27:493-497.
44. Roberts, R. L., and E. R. Stiehm. 1989. Increased phagocytic cell chemiluminescence in patients with cystic fibrosis. Am. J. Dis. Child. 143:944-950.
45. E, in Escherichia coli. EMBO J. 14:1032-1042.
46. E) which controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa. J. Bacteriol. 177:5670-5679.
47. Schurr, M. J., H. Vu, J. Salazar-Martinez, J. C. Boucher, and V. Deretic. Control of AlgU, founding member of a family of stress σ factors, and P. aeruginosa conversion to mucoidy in cystic fibrosis. Submitted for publication.
48. Simpson, J. A., S. E. Smith, and R. T. Dean. 1988. Alginate inhibition of the uptake of Pseudotnonas aeruginosa by macrophages. J. Gen. Microbiol. 134:29-36.
49. Simpson, J. A., S. E. Smith, and R. T. Dean. 1989. Scavenging by alginate of free radicals released by macrophages. Free Radical Biol. Med. 6:347-353.
50. Simpson, J. A., S. E. Smith, and R. T. Dean. 1993. Alginate may accumulate in cystic fibrosis lung because the enzymatic and free radical capacities of phagocytic cells are inadequate for its degradation. Biochem. Mol. Biol. Int. 30:1021-1034.
51. Speert, D. P. 1994. Pseudomonas aeruginosa infections in patients with cystic fibrosis, p. 183-236. In A. L. Baltch and R. P. Smith (ed.), Pseudomonas aeniginosa infections and treatment. Marcel Dekker, New York.
52. Speert, D. P., M. Bond, R. C. Woodman, and J. T. Curnutte. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J. Infect. Dis. (70:1524-1531.
53. Watson, J., K. Kelly, and C. Whltlock. 1980. Genetic control of endotoxin sensitivity, p. 4-10. In D. Schlessinger (ed.), Microbiology-1980. American Society for Microbiology, Washington, D.C.
54. Welkos, S., and A. O'Brien. 1994. Determination of median lethal and Infectious doses in animal model systems. Methods Enzymol. 235:29-39.
55. Yu, H., M. J. Schurr, J. C. Boucher, J. M. Martinez-Salazar, D. W. Martin, and V. Deretlc. Molecular mechanism of conversion to mucoidy in Pseudomonas aentginosa. In S. Silver, T. Nakazawa, and D. Haas (ed.), Molecular biology of pseudomonads, in press. American Society for Microbiology, Washington, D.C.
56. E and Pseudomonas aentginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P aeruginosa. J. Bacteriol. 177:3259-3268.